Remove contact
article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

But the question is, to what extent do health care providers need to worry about FDA requirements as they use AI? FDA has been regulating machine learning algorithms used in a clinical context for decades. It’s important to understand that FDA regulation isn’t punitive in the sense that it’s only intended to apply to bad people.

FDA 98
article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Issues Final Guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertising

Hall Render

Under the Federal Food, Drug, and Cosmetic Act and the FDA’s implementing regulations , “drug promotional labeling and prescription drug advertising must be truthful and non-misleading, convey information about the drug’s efficacy and its risks in a balanced manner and reveal material facts about the drug.”

FDA 40
article thumbnail

FDA Expands Access to Mifepristone: Next Steps for Providers and Retail Pharmacies

Hall Render

Food and Drug Administration (“FDA”) released an updated Mifepristone Risk Evaluation and Mitigation Strategy (the “Mifepristone REMS Program”), which reverses the requirement that the drug be dispensed directly to a patient by certified prescriber in a clinic or a medical office (the “in-person dispensing requirement”).

FDA 40
article thumbnail

Coronavirus is Deregulating Healthcare One FDA Guidance At a Time

VW Health Care Law Blog

One unintended consequence of COVID-19 has been the paradigm shift within the healthcare industry which has turned to prioritize value-based, patient centric remote monitoring solutions and non-contact technologies.

FDA 40
article thumbnail

Synthetic Data and LLMs Power the World’s Most Powerful Research Assistant

Healthcare IT Today

The next public health pronouncement or clinical treatment might emerge from synthetic data : rows of totally invented people that contain no real data but reflects the actual characteristics of a population such as race, gender, and medical conditions. ” The FDA, VA, and others are using synthetic data.

FDA 97
article thumbnail

Modernization of Cosmetics Regulation Act of 2022: What You Need to Know

Healthcare Law Today

Food & Drug Administration (FDA or Agency) the authority to order a mandatory recall of a cosmetic product and to suspend a facility registration if FDA determines there are serious adverse health concerns. Furthermore, MoCRA grants the U.S. MOCRA’s key provisions are outlined below.

FDA 98